Movatterモバイル変換


[0]ホーム

URL:


DK1521572T3 - Biologisk nedbrydelig film til indförsel af öjenlægemiddel - Google Patents

Biologisk nedbrydelig film til indförsel af öjenlægemiddel

Info

Publication number
DK1521572T3
DK1521572T3DK03764333TDK03764333TDK1521572T3DK 1521572 T3DK1521572 T3DK 1521572T3DK 03764333 TDK03764333 TDK 03764333TDK 03764333 TDK03764333 TDK 03764333TDK 1521572 T3DK1521572 T3DK 1521572T3
Authority
DK
Denmark
Prior art keywords
import
biodegradable film
eye drug
film
drug
Prior art date
Application number
DK03764333T
Other languages
English (en)
Inventor
Janet D Howie
Youqin Tian
David Allen Marsh
Bhagwati P Kabra
Gustav Graff
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon IncfiledCriticalAlcon Inc
Application grantedgrantedCritical
Publication of DK1521572T3publicationCriticalpatent/DK1521572T3/da

Links

Classifications

Landscapes

DK03764333T2002-07-152003-06-30Biologisk nedbrydelig film til indförsel af öjenlægemiddelDK1521572T3 (da)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US39584002P2002-07-152002-07-15
US43272102P2002-12-122002-12-12
PCT/US2003/020706WO2004006889A1 (en)2002-07-152003-06-30Bioerodible film for ophthalmic drug delivery

Publications (1)

Publication NumberPublication Date
DK1521572T3true DK1521572T3 (da)2009-05-04

Family

ID=30118549

Family Applications (1)

Application NumberTitlePriority DateFiling Date
DK03764333TDK1521572T3 (da)2002-07-152003-06-30Biologisk nedbrydelig film til indförsel af öjenlægemiddel

Country Status (17)

CountryLink
US (1)US8084054B2 (da)
EP (1)EP1521572B1 (da)
JP (1)JP4454019B2 (da)
KR (1)KR101003514B1 (da)
CN (1)CN100500221C (da)
AT (1)ATE424187T1 (da)
AU (1)AU2003247671B2 (da)
CA (1)CA2491312C (da)
CY (1)CY1109606T1 (da)
DE (1)DE60326455D1 (da)
DK (1)DK1521572T3 (da)
ES (1)ES2321083T3 (da)
MX (1)MXPA05000631A (da)
PL (1)PL206379B1 (da)
PT (1)PT1521572E (da)
SI (1)SI1521572T1 (da)
WO (1)WO2004006889A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060257450A1 (en)*2005-03-212006-11-16Sreenivasu MudumbaDrug delivery systems for treatment of diseases or conditions
JP5591226B2 (ja)2008-05-122014-09-17ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション眼内薬物送達装置および関連する方法
US9095404B2 (en)2008-05-122015-08-04University Of Utah Research FoundationIntraocular drug delivery device and associated methods
US9877973B2 (en)2008-05-122018-01-30University Of Utah Research FoundationIntraocular drug delivery device and associated methods
US10064819B2 (en)2008-05-122018-09-04University Of Utah Research FoundationIntraocular drug delivery device and associated methods
SG173167A1 (en)2009-01-292011-08-29Forsight Labs LlcPosterior segment drug delivery
US8623395B2 (en)2010-01-292014-01-07Forsight Vision4, Inc.Implantable therapeutic device
WO2013022801A1 (en)2011-08-052013-02-14Forsight Vision4, Inc.Small molecule delivery with implantable therapeutic device
CN103189097B (zh)*2010-07-292016-01-06参天制药株式会社带药剂的支承体及其制造方法
JP6111194B2 (ja)2010-08-052017-04-05フォーサイト・ビジョン フォー・インコーポレーテッド組み合わせ薬物送達方法および装置
WO2012019176A2 (en)2010-08-052012-02-09Forsight Vision4 Inc.Implantable therapeutic device
LT2600930T (lt)2010-08-052021-04-12Forsight Vision4, Inc.Injekcinis aparatas, skirtas vaisto tiekimui
WO2012068549A2 (en)2010-11-192012-05-24Forsight Vision4, Inc.Therapeutic agent formulations for implanted devices
WO2012153870A1 (ja)*2011-05-112012-11-15帝人株式会社緑内障治療材
US20120302954A1 (en)*2011-05-252012-11-29Zhao Jonathon ZExpandable devices coated with a paclitaxel composition
WO2013003620A2 (en)2011-06-282013-01-03Forsight Vision4, Inc.Diagnostic methods and apparatus
EP3903733A1 (en)2011-09-162021-11-03ForSight Vision4, Inc.Fluid exchange apparatus
US10010448B2 (en)2012-02-032018-07-03Forsight Vision4, Inc.Insertion and removal methods and apparatus for therapeutic devices
CA2878680C (en)2012-07-232019-09-17Crayola, LlcDissolvable films and methods of using the same
US9968603B2 (en)2013-03-142018-05-15Forsight Vision4, Inc.Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
AU2014241163B2 (en)2013-03-282018-09-27Forsight Vision4, Inc.Ophthalmic implant for delivering therapeutic substances
JP6581194B2 (ja)2014-07-152019-09-25フォーサイト・ビジョン フォー・インコーポレーテッドForsight Vision4, Inc.眼用インプラント送達装置および方法
AU2015301054B2 (en)2014-08-082020-05-14Forsight Vision4, Inc.Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
KR20170106298A (ko)2014-11-102017-09-20포사이트 비젼4, 인크.확장 가능한 약물 전달 장치 및 이용 방법
MX2018006234A (es)2015-11-202018-08-14Forsight Vision4 IncEstructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
WO2017176886A1 (en)2016-04-052017-10-12Forsight Vision4, Inc.Implantable ocular drug delivery devices
WO2019103906A1 (en)2017-11-212019-05-31Forsight Vision4, Inc.Fluid exchange apparatus for expandable port delivery system and methods of use
USD1033637S1 (en)2022-01-242024-07-02Forsight Vision4, Inc.Fluid exchange device
WO2024059952A1 (en)*2022-09-232024-03-28Madd Ophthalmics Ltd.Mucoadhesive drug delivery systems and methods of use

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPS6042766B2 (ja)*1978-12-091985-09-25日本化薬株式会社基剤
GB8524421D0 (en)*1985-10-031985-11-06Boots Co PlcTherapeutic agents
US4880636A (en)*1988-05-131989-11-14Franz Robert MFilm coated tablet of ranitidine HCl
US4865846A (en)*1988-06-031989-09-12Kaufman Herbert EDrug delivery system
US6117425A (en)*1990-11-272000-09-12The American National Red CrossSupplemented and unsupplemented tissue sealants, method of their production and use
HU219242B (en)*1991-05-132001-03-28Boots Co PlcS(+)-ibuprofen sodium salt dihydrate, pharmaceutical composition comprising this compound and process for production of them
GB9213077D0 (en)*1992-06-191992-08-05Erba Carlo SpaPolymerbound taxol derivatives
US5614549A (en)*1992-08-211997-03-25Enzon, Inc.High molecular weight polymer-based prodrugs
US5362478A (en)*1993-03-261994-11-08Vivorx Pharmaceuticals, Inc.Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US6096331A (en)*1993-02-222000-08-01Vivorx Pharmaceuticals, Inc.Methods and compositions useful for administration of chemotherapeutic agents
US6537579B1 (en)1993-02-222003-03-25American Bioscience, Inc.Compositions and methods for administration of pharmacologically active compounds
EP0693924B2 (en)*1993-02-222008-04-09Abraxis BioScience, Inc.Methods for (in vivo) delivery of biologics and compositions useful therefor
US5916596A (en)*1993-02-221999-06-29Vivorx Pharmaceuticals, Inc.Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5439686A (en)*1993-02-221995-08-08Vivorx Pharmaceuticals, Inc.Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5665382A (en)*1993-02-221997-09-09Vivorx Pharmaceuticals, Inc.Methods for the preparation of pharmaceutically active agents for in vivo delivery
US5716981A (en)*1993-07-191998-02-10Angiogenesis Technologies, Inc.Anti-angiogenic compositions and methods of use
TW406020B (en)*1993-09-292000-09-21Bristol Myers Squibb CoStabilized pharmaceutical composition and its method for preparation and stabilizing solvent
US5433951A (en)*1993-10-131995-07-18Bristol-Myers Squibb CompanySustained release formulation containing captopril and method
US5484608A (en)*1994-03-281996-01-16Pharmavene, Inc.Sustained-release drug delivery system
US5626862A (en)*1994-08-021997-05-06Massachusetts Institute Of TechnologyControlled local delivery of chemotherapeutic agents for treating solid tumors
US6063116A (en)*1994-10-262000-05-16Medarex, Inc.Modulation of cell proliferation and wound healing
US5783178A (en)*1994-11-181998-07-21Supratek Pharma. Inc.Polymer linked biological agents
US6369116B1 (en)*1995-06-022002-04-09Oculex Pharmaceuticals, Inc.Composition and method for treating glaucoma
RU2086218C1 (ru)1995-07-261997-08-10Санкт-Петербургская медицинская академия последипломного образованияСпособ лечения глаукомы
US5736152A (en)*1995-10-271998-04-07Atrix Laboratories, Inc.Non-polymeric sustained release delivery system
EP1616563A3 (en)1996-05-242006-01-25Angiotech Pharmaceuticals, Inc.Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases
US5888493A (en)*1996-12-051999-03-30Sawaya; Assad S.Ophthalmic aqueous gel formulation and related methods
KR100923172B1 (ko)1997-06-272009-10-22아브락시스 바이오사이언스, 엘엘씨신규 약물 제제
US6004573A (en)*1997-10-031999-12-21Macromed, Inc.Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US20020164374A1 (en)1997-10-292002-11-07John JacksonPolymeric systems for drug delivery and uses thereof
US6146659A (en)*1998-07-012000-11-14Neopharm, Inc.Method of administering liposomal encapsulated taxane
US6017948A (en)*1998-10-302000-01-25Supergen, Inc.Water-miscible pharmaceutical compositions
CA2367387C (en)*1999-03-162009-06-23Herwig BuchholzComposition comprising isoquercetin and ascorbic acid in a sustained release form
WO2000064437A1 (en)1999-04-222000-11-02American Biosciences, Inc.Long term administration of pharmacologically active agents
US6306120B1 (en)*1999-06-072001-10-23Ben Gee TanApplicator and method for delivery of mitomycin to eye tissues during glaucoma filtering surgery
US6375963B1 (en)*1999-06-162002-04-23Michael A. RepkaBioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
EP1387676A2 (en)*2001-05-012004-02-11Angiotech Pharmaceuticals, Inc.Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
US20040058313A1 (en)*2002-04-242004-03-25Abreu Marcio MarcCompositions, targets, methods and devices for the therapy of ocular and periocular disorders

Also Published As

Publication numberPublication date
WO2004006889A1 (en)2004-01-22
AU2003247671A1 (en)2004-02-02
EP1521572A1 (en)2005-04-13
EP1521572B1 (en)2009-03-04
CA2491312A1 (en)2004-01-22
CY1109606T1 (el)2014-08-13
JP4454019B2 (ja)2010-04-21
CN1668278A (zh)2005-09-14
KR20050025961A (ko)2005-03-14
ATE424187T1 (de)2009-03-15
US20040126408A1 (en)2004-07-01
SI1521572T1 (sl)2009-06-30
MXPA05000631A (es)2005-03-31
CA2491312C (en)2011-05-31
PL374764A1 (en)2005-10-31
DE60326455D1 (de)2009-04-16
PL206379B1 (pl)2010-08-31
ES2321083T3 (es)2009-06-02
KR101003514B1 (ko)2010-12-30
US8084054B2 (en)2011-12-27
PT1521572E (pt)2009-04-21
AU2003247671B2 (en)2008-02-14
CN100500221C (zh)2009-06-17
JP2005533106A (ja)2005-11-04

Similar Documents

PublicationPublication DateTitle
DK1521572T3 (da)Biologisk nedbrydelig film til indförsel af öjenlægemiddel
DE60135486D1 (de)Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung
PT1061900E (pt)Composicoes e metodos para libertacao de uma droga
MX344532B (es)Composiciones de farmaco de liberacion sostenida convenientemente implantables.
CY1105877T1 (el)Οφθαλμικες συνθεσεις πepιεχουσες συνepγιστικο συνδυασμο τριων πολυμepων
CY1115707T1 (el)Στερεα σταθεροποιημενα θεραπευτικα συστηματα ταχειας και/ή τροποποιημενης απελευθερωσης για τη χορηγηση απο του στοματος υγρων δραστικων ουσιων, εκδοχων ή τροφιμων
WO2004009445A3 (en)Packaging and dispensing of rapid dissolve dosage form
MA34832B1 (fr)Compositions biodegradables d'administration de medicaments
MX2009008170A (es)Nuevos biomateriales para la distribucion de farmaco ocular y metodo para hacerlos y utilizarlos.
AU2003237288A1 (en)Biodegradable block copolymeric compositions for drug delivery
DE60330144D1 (de)Beschichtung von stents mit verzögerter wirkstofffreisetzung
WO2008011125A3 (en)Devices, systems and methods for ophthalmic drug delivery
HUP0203451A2 (hu)Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
CY1108700T1 (el)Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
EA200501819A1 (ru)Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке
BR0313428A (pt)Composições farmacêuticas de drogas semi-ordenados e polìmeros
HRP20080178T3 (en)Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
DK1957037T3 (da)Farmaceutisk præparat til nasal anvendelse af fentanyl
WO2008027793A3 (en)Ophthalmic pharmaceutical compositions and uses thereof
WO2002034240A3 (en)Delayed and sustained release formulations and method of use thereof
DE602006012962D1 (de)Pharmazeutische Zubereitungen von Ciprofloxacin
WO2006060325A3 (en)Coated drug delivery formulations
AU2003256882A1 (en)Methods of drug delivery using sulphated chitinous polymers
TR200601092T1 (tr)İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar.
EA200601015A1 (ru)Пероральные композиции дезоксипеганина и их применение

[8]ページ先頭

©2009-2025 Movatter.jp